Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2011

Conditions
Chronic Lymphocytic Leukemia
Interventions
BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (18)

22457

Praxis fur Innere Medizin - Hamburg, Hamburg

28239

DIAKO Ev. Diakonie Krankenhaus gGmbH, Bremen

34117

Internistische Gemeinschaftspraxis - Kassel, Kassel

35392

Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie, Giessen

36251

Kreiskrankenhaus, Bad Hersfeld

58095

St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH, Hagen

70199

Marienhospital Stuttgart, Stuttgart

96317

Internistische Onkologische Praxis - Kronach, Kronach

D-50924

Medizinische Universitaetsklinik I at the University of Cologne, Cologne

D-45122

Universitaetsklinikum Essen, Essen

D-58095

Allgemeines Krankenhaus Hagen, Hagen

D-20099

Asklepios Klinik St. Georg, Hamburg

D-44625

Marienhospital at Ruhr University Bochum, Herne

D-55743

Clinic for Bone Marrow Transplantation and Hematology and Oncology, Idar-Oberstein

D-81377

Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich

D-26133

Klinikum Oldenburg, Oldenburg

D-92637

Haematologische Praxis, Weiden

D-97070

Medizinische Poliklinik, Universitaet Wuerzburg, Würzburg

All Listed Sponsors
lead

German CLL Study Group

OTHER

NCT00309881 - Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) | Biotech Hunter | Biotech Hunter